HLA class I molecules consistently present internal influenza epitopes
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Cytotoxic T lymphocytes (CTL) limit influenza virus replication and prevent morbidity and mortality upon recognition of HLA class I presented epitopes on the surface of virus infected cells, yet the number and origin of the viral epitopes that decorate the infected cell are unknown. To understand the presentation of influenza virus ligands by human MHC class I molecules, HLA-B*0702-presented viral peptides were directly identified following influenza infection. After transfection with soluble class I molecules, peptide ligands unique to infected cells were eluted from isolated MHC molecules and identified by comparative mass spectrometry (MS). Then CTL were gathered following infection with influenza and viral peptides were tested for immune recognition. We found that the class I molecule B*0702 presents 3–6 viral ligands following infection with different strains of influenza. Peptide ligands derived from the internal viral nucleoprotein (NP 418–426 and NP 473–481 ) and from the internal viral polymerase subunit PB1 (PB1 329–337 ) were presented by B*0702 following infection with each of 3 different influenza strains; ligands NP 418–426 , NP 473–481 , and PB1 329–337 derived from internal viral proteins were consistently revealed by class I HLA. In contrast, ligands derived from hemagglutinin (HA) and matrix protein (M1) were presented intermittently on a strain-by-strain basis. When tested for immune recognition, HLA-B*0702 transgenic mice responded to NP 418–426 and PB1 329–337 consistently and NP 473–481 intermittently while ligands from HA and M1 were not recognized. These data demonstrate an emerging pattern whereby class I HLA reveal a handful of internal viral ligands and whereby CTL recognize consistently presented influenza ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This approach can yield substantial quantities of HLA-peptide complexes that can be easily purified from the medium before nUPLC-MS/MS analysis.”
From Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLA class I supertypes: a revised and updated classification
Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-1 · Cited by 775
Research works printed but not linked: 42
- 10.1126/science.3257585 · DOI · Paper page
- 10.1093/oxfordjournals.bmb.a071545 · DOI · Paper page
- JL Virelizier, Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 115, 434–439 (1975). · DOI · Paper page
- 10.1128/jvi.13.2.269-275.1974 · doi:10.1128/jvi.13.2.269-275.1974
- 10.1128/JVI.78.10.5216-5222.2004 · doi:10.1128/jvi.78.10.5216-5222.2004
- 10.1128/jvi.76.5.2567-2572.2002 · DOI
- 10.1128/JVI.74.15.6800-6807.2000 · DOI · Paper page
- 10.4049/jimmunol.172.7.4435 · DOI
- 10.1371/journal.pbio.0030091 · DOI · Paper page
- 10.1038/nature03113 · DOI · Paper page
- 10.4049/jimmunol.176.7.4094 · DOI · Paper page
- 10.1046/j.0300-9475.2001.01043.x · DOI
- 10.1128/JVI.76.2.582-590.2002 · DOI
- 10.1034/j.1399-0039.2003.00062.x · DOI · Paper page
- 10.1002/eji.1830260210 · doi:10.1002/eji.1830260210
- 10.1128/JVI.02005-07 · DOI · Paper page
- 10.1016/j.smim.2004.02.004 · DOI · Paper page
- 10.1111/j.0105-2896.2006.00385.x · DOI
- 10.3201/eid1201.051237 · DOI · Paper page
- KA Wall, et al., A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. J Immunol 152, 4526–4536 (1994). · DOI
- 10.1046/j.1365-2249.2001.01613.x · DOI
- 10.1093/intimm/dxg073 · DOI
- 10.1128/JVI.00009-06 · DOI
- BR Murphy, ML Clements, The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 146, 107–116 (1989).
- 10.1006/smvy.1996.0033 · DOI
- SL Epstein, CY Lo, JA Misplon, JR Bennink, Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 160, 322–327 (1998). · DOI · Paper page
- 10.1073/pnas.0711874105 · DOI
- 10.1371/journal.pone.0001190 · DOI · Paper page
- S Man, JP Ridge, VH Engelhard, Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice. J Immunol 153, 4458–4467 (1994). · doi:10.4049/jimmunol.153.10.4458
- 10.1093/intimm/7.4.597 · DOI · Paper page
- 10.1038/326881a0 · DOI · Paper page
- 10.1046/j.1440-1711.2002.01088.x · DOI
- 10.1128/JVI.79.17.11239-11246.2005 · DOI
- P Parham, CJ Barnstable, WF Bodmer, Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J Immunol 123, 342–349 (1979). · DOI · Paper page
- 10.1007/s002510050219 · DOI
- 10.1006/bbrc.1994.1419 · doi:10.1006/bbrc.1994.1419
- 10.1586/14789450.3.6.641 · DOI
- 10.1016/S0198-8859(00)00216-0 · doi:10.1016/s0198-8859(00)00216-0
- 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 · DOI · Paper page
- 10.1021/bi050255v · DOI · Paper page
- 10.1016/j.jim.2006.05.010 · doi:10.1016/j.jim.2006.05.010
- 10.1021/bi048580q · doi:10.1021/bi048580q
Cited by
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 394
Efficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection
Lazarus, D., Weinstein-Marom, H., Fishman, S., Yossef, R., Zuri, D., Barnea, E., Admon, A., Margalit, A., & Gross, G. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.03.008 · Cited by 7
Metadata
- Authors
- Wahl, A., Schafer, F., Bardet, W., Buchli, R., Air, G. M., & Hildebrand, W. H.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-01-13
- Volume
- 106
- Issue
- 2
- Pages
- 540-545
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 60
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.